Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2004 2
2005 2
2006 3
2007 1
2008 6
2009 3
2010 4
2011 3
2012 1
2013 3
2014 9
2015 11
2016 15
2017 11
2018 4
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

73 results
Results by year
Filters applied: . Clear all
Page 1
Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
Liu Y, Hazlewood GS, Kaplan GG, Eksteen B, Barnabe C. Liu Y, et al. Among authors: eksteen b. Arthritis Care Res (Hoboken). 2017 Feb;69(2):157-165. doi: 10.1002/acr.22932. Epub 2016 Dec 31. Arthritis Care Res (Hoboken). 2017. PMID: 27159376 Free article. Review.
Retraction notice to: PS124-Efficacy and Safety of Induction Dosing of Vedolizumab for Reducing Biliary Inflammation in Primary Sclerosing Cholangitis (PSC) in Individuals with Inflammatory Bowel Disease [J Hepatol 64 (2016) S199].
Eksteen B, Heatherington J, Oshiomogo J, Panaccione R, Kaplan G, Ghosh S. Eksteen B, et al. J Hepatol. 2017 Jan;66(1):254. doi: 10.1016/j.jhep.2016.10.020. Epub 2016 Dec 15. J Hepatol. 2017. PMID: 28042931 No abstract available.
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, Holm K, Gotthardt D, Färkkilä MA, Marschall HU, Thorburn D, Weersma RK, Fevery J, Mueller T, Chazouillères O, Schulze K, Lazaridis KN, Almer S, Pereira SP, Levy C, Mason A, Naess S, Bowlus CL, Floreani A, Halilbasic E, Yimam KK, Milkiewicz P, Beuers U, Huynh DK, Pares A, Manser CN, Dalekos GN, Eksteen B, Invernizzi P, Berg CP, Kirchner GI, Sarrazin C, Zimmer V, Fabris L, Braun F, Marzioni M, Juran BD, Said K, Rupp C, Jokelainen K, Benito de Valle M, Saffioti F, Cheung A, Trauner M, Schramm C, Chapman RW, Karlsen TH, Schrumpf E, Strassburg CP, Manns MP, Lindor KD, Hirschfield GM, Hansen BE, Boberg KM; International PSC Study Group. Weismüller TJ, et al. Among authors: eksteen b. Gastroenterology. 2017 Jun;152(8):1975-1984.e8. doi: 10.1053/j.gastro.2017.02.038. Epub 2017 Mar 6. Gastroenterology. 2017. PMID: 28274849 Free PMC article.
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
Trauner M, Gulamhusein A, Hameed B, Caldwell S, Shiffman ML, Landis C, Eksteen B, Agarwal K, Muir A, Rushbrook S, Lu X, Xu J, Chuang JC, Billin AN, Li G, Chung C, Subramanian GM, Myers RP, Bowlus CL, Kowdley KV. Trauner M, et al. Among authors: eksteen b. Hepatology. 2019 Sep;70(3):788-801. doi: 10.1002/hep.30509. Epub 2019 Mar 10. Hepatology. 2019. PMID: 30661255 Free PMC article. Clinical Trial.
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.
Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, Kumasaka N, Atkinson EJ, Schlicht EM, Liu JZ, Shah T, Gutierrez-Achury J, Boberg KM, Bergquist A, Vermeire S, Eksteen B, Durie PR, Farkkila M, Müller T, Schramm C, Sterneck M, Weismüller TJ, Gotthardt DN, Ellinghaus D, Braun F, Teufel A, Laudes M, Lieb W, Jacobs G, Beuers U, Weersma RK, Wijmenga C, Marschall HU, Milkiewicz P, Pares A, Kontula K, Chazouillères O, Invernizzi P, Goode E, Spiess K, Moore C, Sambrook J, Ouwehand WH, Roberts DJ, Danesh J, Floreani A, Gulamhusein AF, Eaton JE, Schreiber S, Coltescu C, Bowlus CL, Luketic VA, Odin JA, Chopra KB, Kowdley KV, Chalasani N, Manns MP, Srivastava B, Mells G, Sandford RN, Alexander G, Gaffney DJ, Chapman RW, Hirschfield GM, de Andrade M; UK-PSC Consortium; International IBD Genetics Consortium; International PSC Study Group, Rushbrook SM, Franke A, Karlsen TH, Lazaridis KN, Anderson CA. Ji SG, et al. Among authors: eksteen b. Nat Genet. 2017 Feb;49(2):269-273. doi: 10.1038/ng.3745. Epub 2016 Dec 19. Nat Genet. 2017. PMID: 27992413 Free PMC article.
Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
Lambert JE, Parnell JA, Eksteen B, Raman M, Bomhof MR, Rioux KP, Madsen KL, Reimer RA. Lambert JE, et al. Among authors: eksteen b. BMC Gastroenterol. 2015 Dec 3;15:169. doi: 10.1186/s12876-015-0400-5. BMC Gastroenterol. 2015. PMID: 26635079 Free PMC article. Clinical Trial.
The Gut-Liver Axis in Primary Sclerosing Cholangitis.
Eksteen B. Eksteen B. Clin Liver Dis. 2016 Feb;20(1):1-14. doi: 10.1016/j.cld.2015.08.012. Epub 2015 Sep 26. Clin Liver Dis. 2016. PMID: 26593287 Review.
Predicting risk in primary biliary cholangitis.
Eksteen B. Eksteen B. Hepatology. 2016 Mar;63(3):697-9. doi: 10.1002/hep.28377. Epub 2016 Jan 14. Hepatology. 2016. PMID: 26638198 No abstract available.
Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease.
Reyes JL, Vannan DT, Eksteen B, Avelar IJ, Rodríguez T, González MI, Mendoza AV. Reyes JL, et al. Among authors: eksteen b. Mediators Inflamm. 2018 Aug 12;2018:2532314. doi: 10.1155/2018/2532314. eCollection 2018. Mediators Inflamm. 2018. PMID: 30158831 Free PMC article. Review.
Gastroenterology.
Jankowski J, de Caestecker J, Eksteen B, Perry I. Jankowski J, et al. Among authors: eksteen b. BMJ. 2002 Oct 12;325(7368):S113. doi: 10.1136/bmj.325.7368.s113a. BMJ. 2002. PMID: 12376456 No abstract available.
73 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback